Organon Ireland chooses Kuehne + Nagel as logistics partner

Published: 7-Jun-2006

Kuehne + Nagel Ireland has been awarded a contract to manage the global logistics requirements for health care company Organon Ireland. The agreement includes road, sea and air ambient/cool chain logistics services.


Kuehne + Nagel Ireland has been awarded a contract to manage the global logistics requirements for health care company Organon Ireland. The agreement includes road, sea and air ambient/cool chain logistics services.

The human health care business unit of Akzo Nobel, Organon develops, manufactures and markets a range of prescription medicines including products in the fields of gynecology, mental health, anesthesia, and fertility. One of its two global manufacturing sites is located on a 31-acre site near Swords Village, Co Dublin, employing approximately 600 people. The products manufactured there are packaged for export to over 50 countries.

The company has been looking to form a partnership with a logistics service provider that has global coverage. Kuehne + Nagel is one of the leading logistics companies with a strong market position in seafreight, airfreight and contract logistics businesses and was able to offer full visibility for all shipments globally, efficient transport solutions and a partnership approach.

Under the scope of the contract Kuehne + Nagel will manage the inbound transportation by road, sea and air to the Organon facility in Swords and outbound transportation by road, sea and air including temperature controlled/cold chain services to Organon's global customer base.

Gerry Coughlan, logistics director for Organon Ireland, said: "In order to successfully compete in a global environment it is important for us to work in a partnership with suppliers who can deliver a value-added service. This new collaboration with Kuehne + Nagel will allow us to further enhance our already high level of service to our customers."

See more

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

Read more
The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Improving healthcare has led to a higher salt requirement

The number of dialysis treatments is increasing across the globe, mainly due to an increasing number of patients and improved healthcare in many developing countries
Training & Education

AkzoNobel helps develop next generation of skilled workers

The company's commitment to inspiring young minds will be recognised in the Employer of the Year category of the inaugural Industrial Cadets Awards
Media

Schering-Plough acquisition of Organon BioSciences gets European Commission approval

<p>Schering-Plough Corporation has received approval from the European Commission for its planned acquisition of Organon BioSciences from Akzo Nobel as announced in March.</p>

Consortium to develop a pandemic flu vaccine

<p>A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential mergency vaccination. </p>
Sustainability

Xceleron and Organon sign microdose study agreement

<p>UK company Xceleron has signed a collaboration agreement with Organon, the human healthcare business unit of Akzo Nobel, on a three-compound human microdose study focusing on candidate selection for further clinical development. </p>
Sustainability

Organon and MRC Technology sign antibody development agreement

<p>Organon, the human healthcare business unit of Akzo Nobel, together with MRC Technology, of London in the UK, have signed a collaborative agreement to develop a humanised antibody for the treatment of certain forms of cancer. </p>
Sustainability

Organon and Dyax enter into therapeutic antibody alliance

<p>Organon, the human healthcare business unit of Akzo Nobel, has entered into an agreement with Dyax Corp. to discover and develop human therapeutic antibodies for the treatment of auto-immune diseases and cancer. </p>
Subscribe now